A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease

In this study population, treatment with alglucosidase alfa was associated with improved walking distance and stabilization of pulmonary function over an 18-month period. (ClinicalTrials.gov number, NCT00158600.)